Table 3. Prognosis of Undiagnosed Patients Receiving Empiric Therapy or Observational Follow-up .
| Prognosis |
Empiric Therapy*
(n=21) |
Observational Follow-up
(n=20) |
P |
| Clinical symptom | 0.488 | ||
| Improved | 21 (100.0%) | 19 (95.0%) | |
| Unchanged | 0 (0.0%) | 1 (5.0%) | |
| Endoscopic finding | 0.258 | ||
| Improved | 8 (38.1%) | 9 (45.0%) | |
| Unchanged | 3 (14.3%) | 0 (0.0%) | |
| Aggravating | 0 (0.0%) | 1 (5.0%) | |
| Unknown | 10 (47.6%) | 10 (50.0%) |
*Empiric therapy includes 5-ASA, probiotics, and 5-ASA plus probiotics.